Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed journal focused on the interdisciplinary fields of psychotherapy, psychosomatics, and medical psychology. Since its inception in 1980, this journal has emerged as a significant platform for researchers and professionals to disseminate findings that bridge psychological theory and clinical practice, significantly contributing to the advancement of applied psychology, clinical psychology, and psychiatry. With an ongoing convergence of research until 2024, the journal maintains a vital role in its field, holding a Q3 ranking in multiple categories as of 2023, reflecting its relevance and quality within the academic community. Though not an open-access journal, it provides crucial insights that influence both scholarly discourse and clinical methodologies, making it an essential resource for anyone engaged in understanding the complexities of mental health and psychosomatic conditions.

BMJ Open is a distinguished open access journal published by the BMJ Publishing Group, dedicated to advancing the field of medicine through the dissemination of high-quality research. Since its inception in 2011, this journal has positioned itself as a pivotal platform in the medical arena, presently classified in the Q1 category of Medicine (Miscellaneous) for 2023, reflecting its commitment to excellence as evidenced by its Scopus ranking of #117 out of 636, placing it in the top 81st percentile. With its open access model, BMJ Open ensures that research is readily available to a global audience, promoting collaboration and knowledge sharing among researchers, healthcare professionals, and students alike. Located in London, UK, the journal is committed to featuring innovative research that informs clinical practice, public health, and healthcare policy, making it an essential resource for anyone engaged in medical research and practice.

Archives of Medical Science is a prestigious open-access journal dedicated to the dissemination of high-quality research in the field of medicine, encompassing a broad spectrum of medical sciences. Published by TERMEDIA PUBLISHING HOUSE LTD and operating from Poland, this journal has established itself as a vital platform for innovative findings and insightful reviews since its inception in 2005. With an impressive impact factor and ranked Q2 in the medicine (miscellaneous) category, it has garnered recognition within the global scientific community, currently placed in the 84th percentile according to Scopus rankings. The journal covers a range of topics that reflect current trends and advancements in medicine, offering valuable resources to researchers, professionals, and students. Its commitment to open access ensures that research is readily available to a wider audience, fostering collaboration and knowledge sharing. With contributions from leading experts, Archives of Medical Science is poised to continue influencing medical practices and policies well into the future.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Integrative Medicine Research, published by Elsevier, is a premier journal dedicated to advancing the field of Complementary and Alternative Medicine. With an impact factor that reflects its esteemed position—ranking 15th out of 105 journals in its category as of 2023 and placing in the 86th percentile—this journal serves as a pivotal platform for researchers, professionals, and students alike. Since its transition to an Open Access model in 2012, it has enhanced the dissemination of critical research, fostering collaboration and application of integrative approaches to health and wellness. The journal encompasses a wide array of topics within its scope, encouraging submissions that contribute to the evidence base of integrative practices and their effects on health outcomes. As a quarterly publication based in South Korea, it emphasizes the importance of global perspectives in research, thereby inspiring innovation in complementary healthcare practices.

The Iranian Journal of Psychiatry and Clinical Psychology, a distinguished publication by IRAN UNIV MEDICAL SCIENCES, serves as a vital platform for the dissemination of research and advancements in the fields of clinical psychology and psychiatry. With its ISSN 1735-4315 and E-ISSN 2228-7515, the journal reaches a diverse audience of researchers, practitioners, and students, specifically in Iran and the broader international community. This open access journal, based in Tehran, facilitates knowledge sharing through its commitment to exploring contemporary issues and emerging trends from 2018 to 2024. Recognized for its significant contributions, it has achieved a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories in 2023, alongside Scopus rankings that place it within the lower quartiles of its respective fields. The journal's aim is to foster a deeper understanding of mental health challenges, promote evidence-based practices, and enhance the quality of mental health care, making it an essential resource for advancing academic and clinical excellence.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

Functional Foods in Health and Disease is a respected peer-reviewed journal published by FUNCTIONAL FOOD CENTER INC, dedicated to advancing research in the fields of biochemistry, food science, medicine, and nutrition. Since its inception in 2011, this journal has provided a platform for innovative studies that connect the impact of functional foods on health and disease outcomes. With a focus on interdisciplinary research, it aims to disseminate knowledge that enhances the understanding of how specific food components can influence health and well-being. The journal is indexed with an ISSN of 2160-3855 and annually ranked in several categories, including Q4 in Biochemistry and Q3 in Food Science, Medicine, and Nutrition and Dietetics for 2023. As an open access publication, it ensures that research is widely accessible, which is crucial for fostering collaboration and discussion within the scientific community. This journal is a vital resource for researchers, practitioners, and students seeking to explore the dynamic role of functional foods in health promotion and disease prevention.